UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED
OR
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM _________________ TO _________________
(Commission file number)
(Exact name of registrant as specified in its charter)
| ||
(State or other jurisdiction of incorporation or organization) | (IRS employer identification number) | |
(Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading symbol(s) |
| Name of each exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section l3 or l5(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Accelerated filer ☐ | |
Non-accelerated filer ☐ | Smaller reporting company |
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
The number of shares of the registrant’s Common Stock, par value $0.01 per share, outstanding as of January 31, 2024 was
Index
2
Part I - Financial Information
Item 1. Consolidated Financial Statements (Unaudited):
KYNDRYL HOLDINGS, INC.
CONSOLIDATED INCOME STATEMENT
(In millions, except per share amounts)
(Unaudited)
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
| 2023 |
| 2022 |
| 2023 |
| 2022 | |||||
Revenues * | $ | | $ | | $ | | $ | | ||||
Cost of services ** | $ | | $ | | $ | | $ | | ||||
Selling, general and administrative expenses | | | | | ||||||||
Workforce rebalancing charges | | | | | ||||||||
Transaction-related costs (benefits) | ( | | | | ||||||||
Interest expense | | | | | ||||||||
Other expense | | | | | ||||||||
Total costs and expenses | $ | | $ | | $ | | $ | | ||||
Income (loss) before income taxes | $ | | $ | ( | $ | ( | $ | ( | ||||
Provision for (benefit from) income taxes | $ | | $ | ( | $ | | $ | | ||||
Net income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Basic earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Diluted earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Weighted-average basic shares outstanding | | | | | ||||||||
Weighted-average diluted shares outstanding | | | | |
* Including related-party revenue of $
** Including related-party cost of services of $
The accompanying notes are an integral part of the financial statements.
3
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS)
(Dollars in millions)
(Unaudited)
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||
| 2023 |
| 2022 | 2023 |
| 2022 | ||||||
Net income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss), before tax: | ||||||||||||
Foreign currency translation adjustments | | | | ( | ||||||||
Unrealized gains (losses) on cash flow hedges: | ||||||||||||
Unrealized gains (losses) arising during the period | ( | ( | | ( | ||||||||
Reclassification of (gains) losses to net income | ( | | ( | | ||||||||
Total unrealized gains (losses) on cash flow hedges | ( | ( | | ( | ||||||||
Retirement-related benefit plans: | ||||||||||||
Amortization of prior service (credits) costs | — | — | | — | ||||||||
Amortization of net (gains) losses | ( | | | | ||||||||
Total retirement-related benefit plans | ( | | | | ||||||||
Other comprehensive income (loss), before tax | | | | ( | ||||||||
Income tax (expense) benefit related to items of other comprehensive income (loss) | | ( | | ( | ||||||||
Other comprehensive income (loss), net of tax | | | | ( | ||||||||
Total comprehensive income (loss) | $ | | $ | | $ | ( | $ | ( |
The accompanying notes are an integral part of the financial statements.
4
KYNDRYL HOLDINGS, INC.
CONSOLIDATED BALANCE SHEET
(In millions, except per share amount)
(Unaudited)
December 31, | March 31, | |||||
| 2023 |
| 2023 | |||
Assets: |
|
| ||||
Current assets: | ||||||
Cash and cash equivalents | $ | | $ | | ||
Restricted cash | | | ||||
Accounts receivable (net of allowances for credit losses of $ | | | ||||
Deferred costs (current portion) |
| |
| | ||
Prepaid expenses and other current assets | | | ||||
Total current assets | $ | | $ | | ||
Property and equipment, net | $ | | $ | | ||
Operating right-of-use assets, net | | | ||||
Deferred costs (noncurrent portion) | | | ||||
Deferred taxes | | | ||||
Goodwill | | | ||||
Intangible assets, net | | | ||||
Pension assets | | | ||||
Other noncurrent assets | | | ||||
Total assets | $ | | $ | | ||
Liabilities: | ||||||
Current liabilities: | ||||||
Accounts payable | $ | | $ | | ||
Value-added tax and income tax liabilities | | | ||||
Current portion of long-term debt | | | ||||
Accrued compensation and benefits |
| |
| | ||
Deferred income (current portion) |
| |
| | ||
Operating lease liabilities (current portion) |
| |
| | ||
Accrued contract costs | | | ||||
Other accrued expenses and liabilities | | | ||||
Total current liabilities | $ | | $ | | ||
Long-term debt | $ | | $ | | ||
Retirement and nonpension postretirement benefit obligations | | | ||||
Deferred income (noncurrent portion) | | | ||||
Operating lease liabilities (noncurrent portion) | | | ||||
Other noncurrent liabilities | | | ||||
Total liabilities | $ | | $ | | ||
Commitments and contingencies | ||||||
Equity: | ||||||
Stockholders’ equity | ||||||
Common stock, par value $ | $ | | $ | | ||
Accumulated deficit | ( | ( | ||||
Treasury stock, at cost (shares: December 31, 2023 – | ( | ( | ||||
Accumulated other comprehensive income (loss) | ( | ( | ||||
Total stockholders’ equity before non-controlling interests | $ | | $ | | ||
Non-controlling interests | | | ||||
Total equity | $ | | $ | | ||
Total liabilities and equity | $ | | $ | |
The accompanying notes are an integral part of the financial statements.
5
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
Nine Months Ended December 31, | ||||||
| 2023 |
| 2022 | |||
Cash flows from operating activities: |
|
|
| |||
Net income (loss) | $ | ( | $ | ( | ||
Adjustments to reconcile net income (loss) to cash provided by operating activities: |
|
| ||||
Depreciation and amortization: |
|
| ||||
Depreciation of property, equipment and capitalized software | | | ||||
Depreciation of right-of-use assets | | | ||||
Amortization of transition costs and prepaid software |
| |
| | ||
Amortization of capitalized contract costs | | | ||||
Amortization of acquisition-related intangible assets |
| |
| | ||
Stock-based compensation | | | ||||
Deferred taxes | | | ||||
Net (gain) loss on asset sales and other | ( | ( | ||||
Change in operating assets and liabilities: | ||||||
Deferred costs (excluding amortization) | ( | ( | ||||
Right-of-use assets and liabilities (excluding depreciation) | ( | ( | ||||
Workforce rebalancing liabilities | ( | ( | ||||
Receivables |
| ( |
| | ||
Accounts payable | ( | | ||||
Taxes | ( | ( | ||||
Other assets and other liabilities |
| ( |
| ( | ||
Net cash provided by operating activities | $ | | $ | | ||
Cash flows from investing activities: |
|
| ||||
Capital expenditures | $ | ( | $ | ( | ||
Proceeds from disposition of property and equipment |
| |
| | ||
Other investing activities, net | ( | ( | ||||
Net cash used in investing activities | $ | ( | $ | ( | ||
Cash flows from financing activities: |
|
| ||||
Debt repayments | $ | ( | $ | ( | ||
Common stock repurchases for tax withholdings |
| ( |
| ( | ||
Other financing activities, net | ( | — | ||||
Net cash provided by (used in) financing activities | $ | ( | $ | ( | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash | $ | ( | $ | ( | ||
Net change in cash, cash equivalents and restricted cash | $ | ( | $ | ( | ||
Cash, cash equivalents and restricted cash at beginning of period | $ | | $ | | ||
Cash, cash equivalents and restricted cash at end of period | $ | | $ | | ||
Supplemental data | ||||||
Income taxes paid, net of refunds received | $ | | $ | | ||
Interest paid on debt | $ | | $ | |
The accompanying notes are an integral part of the financial statements.
6
KYNDRYL HOLDINGS, INC.
CONSOLIDATED STATEMENT OF EQUITY
(In millions)
(Unaudited)
Common Stock and | Accumulated | ||||||||||||||||||||
Additional | Other | Non- | |||||||||||||||||||
Paid-In Capital | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||
Shares | Amount | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||
Equity – October 1, 2023 | | $ | | $ | ( | $ | ( | $ | ( | $ | | $ | | ||||||||
Net income (loss) | ( | ( | |||||||||||||||||||
Other comprehensive income (loss), net of tax | | ||||||||||||||||||||
Common stock issued under employee plans | | ||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ||||||||||||||||||
Changes in non-controlling interests | | ||||||||||||||||||||
Equity – December 31, 2023 | $ | $ | ( | $ | ( | $ | ( | $ | | $ | |
Common Stock and | Accumulated | ||||||||||||||||||||
Additional | Other | Non- | |||||||||||||||||||
Paid-In Capital | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||
Shares | Amount | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||
Equity – October 1, 2022 | | $ | | $ | ( | $ | ( | $ | ( | $ | | $ | | ||||||||
Net income (loss) | ( | ( | |||||||||||||||||||
Other comprehensive income (loss), net of tax | | | |||||||||||||||||||
Common stock issued under employee plans | | ||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ||||||||||||||||||
Changes in non-controlling interests | | | |||||||||||||||||||
Equity – December 31, 2022 | | $ | | $ | ( | $ | ( | $ | ( | $ | $ | |
Common Stock and | Accumulated | ||||||||||||||||||||
Additional | Other | Non- | |||||||||||||||||||
Paid-In Capital | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||
Shares | Amount | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||
Equity – April 1, 2023 | | $ | | $ | ( | $ | ( | $ | ( | $ | | $ | | ||||||||
Net income (loss) | ( | ( | |||||||||||||||||||
Other comprehensive income (loss), net of tax | | | |||||||||||||||||||
Common stock issued under employee plans | | ||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ||||||||||||||||||
Changes in non-controlling interests | | ||||||||||||||||||||
Equity – December 31, 2023 | $ | $ | ( | $ | ( | $ | ( | $ | | $ | |
Common Stock and | Accumulated | ||||||||||||||||||||
Additional | Other | Non- | |||||||||||||||||||
Paid-In Capital | Comprehensive | Treasury | Accumulated | Controlling | Total | ||||||||||||||||
Shares | Amount | Income (Loss) | Stock | Deficit | Interests | Equity | |||||||||||||||
Equity - April 1, 2022 | | $ | | $ | ( | $ | ( | $ | ( | $ | | $ | | ||||||||
Net income (loss) | ( | ( | |||||||||||||||||||
Other comprehensive income (loss), net of tax | ( | ( | |||||||||||||||||||
Common stock issued under employee plans | | ||||||||||||||||||||
Purchases of treasury stock | ( | ( | ( | ||||||||||||||||||
Changes in non-controlling interests | | ||||||||||||||||||||
Equity - December 31, 2022 | $ | $ | ( | $ | ( | $ | ( | $ | | $ | |
The accompanying notes are an integral part of the financial statements.
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Kyndryl Holdings, Inc. (“we”, “the Company” or “Kyndryl”) is a leading technology services company and the largest IT infrastructure services provider in the world, serving as a partner to thousands of enterprise customers whose operations span over
In November 2021, our former Parent effected the spin-off (the “Separation” or the “Spin-off”) of the infrastructure services unit of its Global Technology Services (“GTS”) segment through the distribution of shares of Kyndryl’s common stock to IBM stockholders. Kyndryl’s stock began trading as an independent company on November 4, 2021. In connection with the Separation, the Company entered into several agreements with IBM governing the relationship of the parties following the Separation.
Basis of Presentation
The accompanying Consolidated Financial Statements and footnotes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the accompanying financial statements include all adjustments necessary to state fairly the Company’s financial position and its results of operations for all the periods presented. The information included in this Form 10-Q should be read in conjunction with the Company’s Annual Report for the fiscal year ended March 31, 2023.
Within the financial statements and tables presented, certain columns and rows may not add due to the use of rounded numbers for disclosure purposes. Percentages presented are calculated from the underlying whole-dollar amounts.
Principles of Consolidation
The accompanying financial statements are presented on a consolidated basis. All significant transactions and intercompany accounts between Kyndryl entities were eliminated.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts that are reported in the consolidated financial statements and accompanying disclosures. Estimates are used in determining the following, among others: revenue, costs to complete service contracts, income taxes, pension assumptions, valuation of assets including goodwill and intangible assets, the depreciable and amortizable lives of long-lived assets, loss contingencies, allowance for credit losses and deferred transition costs. Actual results may differ from these estimates.
The Company uses the estimated annual effective tax rate method in computing its interim tax provision in accordance with U.S. GAAP. The estimated annual effective tax rate is applied to the year-to-date ordinary income, exclusive of discrete items, to arrive at the reported interim tax provision.
8
Notes to Consolidated Financial Statements (continued)
NOTE 2. ACCOUNTING PRONOUNCEMENTS
Recent Pronouncements
In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which included a sunset provision within Topic 848 based on expectations of when the London Interbank Offered Rate (“LIBOR”) would cease being published. The FASB issued temporary, optional expedients related to the accounting for contract modifications and hedging transactions as a result of markets transitioning from the use of LIBOR and other interbank offered rates to alternative reference rates. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, deferring the sunset date of Topic 848 to December 31, 2024. In June 2023, the Company modified its contracts that use LIBOR, transitioning from LIBOR to the Secured Overnight Financing Rate (“SOFR”). The use of SOFR became effective in modified contracts beginning on July 1, 2023. The change of reference rate did not result in any material impact to the Company’s consolidated financial statements.
In September 2022, the FASB issued ASU 2022-04, which amended its guidance related to supplier finance programs. The amended guidance requires additional disclosures surrounding the use of supplier finance programs to purchase goods or services, including disclosing the key terms of the programs, the amount of obligations outstanding at the end of the reporting period, and a roll-forward of those obligations. The new guidance, except the roll-forward information, is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The requirement to present roll-forward information is effective for fiscal years beginning after December 15, 2023. The Company adopted the guidance at the beginning of fiscal year 2024. The Company did not have any outstanding obligations under supplier finance programs in the periods presented.
In March 2023, the FASB issued ASU 2023-01, Leases (Topic 842) – Common-Control Arrangements. This guidance amends the accounting for leasehold improvements in common-control arrangements by requiring a lessee in a common-control arrangement to amortize leasehold improvements that it owns over the improvements’ useful life to the common-control group, regardless of the lease term, if the lessee continues to control the use of the underlying asset through a lease. This guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted. The Company has evaluated the impact of the amended guidance and concluded that the guidance does not have a material impact on the Company’s consolidated financial statements.
In August 2023, the FASB issued ASU 2023-05, Business Combinations – Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement which requires a joint venture to measure all contributions received upon its formation at fair value. This guidance should be applied prospectively, effective for all newly-formed joint venture entities with a formation date on or after January 1, 2025. Early adoption is permitted. The Company has evaluated the impact of the guidance and does not expect it to have a material impact on the Company’s consolidated financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures, which is intended to improve reportable segment disclosures, primarily through enhanced disclosures about significant segment expenses. The guidance should be applied retrospectively, effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this guidance will have on the Company’s consolidated financial statements.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) – Improvements to Income Tax Disclosures, which is intended to enhance the transparency and usefulness of income tax disclosures through improved reporting related to the rate reconciliation and income taxes paid. The guidance is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this guidance will have on the Company’s consolidated financial statements.
9
Notes to Consolidated Financial Statements (continued)
NOTE 3. REVENUE RECOGNITION
Disaggregation of Revenue
The Company views its segment results to be the best view of disaggregated revenue. Refer to Note 4 – Segments.
Remaining Performance Obligations
The remaining performance obligation (“RPO”) represents the aggregate amount of contractual deliverables yet to be recognized as revenue at the end of the reporting period. It is intended to be a statement of overall work under contract that has not yet been performed and does not include contracts for which the customer is not committed. The customer is not considered committed when it is able to terminate for convenience without payment of a substantive penalty. The RPO also includes estimates of variable consideration. RPO estimates are subject to change and are affected by several factors, including terminations, changes in the scope of contracts, periodic revalidations, adjustments for revenue that has not materialized and adjustments for currency.
At December 31, 2023, the aggregate amount of RPO related to customer contracts that are unsatisfied or partially unsatisfied was $
During the three and nine months ended December 31, 2023, revenue was increased by $
Contract Balances
The following table provides information about accounts receivable, contract assets and deferred income balances:
December 31, | March 31, | |||||
(Dollars in millions) |
| 2023 |
| 2023 | ||
Accounts receivable (net of allowances for credit losses of $ | $ | | $ | | ||
Contract assets ** |
| |
| | ||
Deferred income (current) |
| |
| | ||
Deferred income (noncurrent) |
| |
| |
* | Including unbilled receivable balances of $ |
** | Contract assets represent goods or services delivered by the Company, which give the Company the right to consideration that is typically subject to milestone completion or client acceptance and are included within prepaid expenses and other current assets in the Consolidated Balance Sheet. |
The amount of revenue recognized during the three and nine months ended December 31, 2023 that was included within the deferred income balance at the beginning of the period was $
10
Notes to Consolidated Financial Statements (continued)
The following table provides roll-forwards of the accounts receivable allowance for credit losses for the nine months ended December 31, 2023 and 2022.
Nine Months Ended December 31, | ||||||
(Dollars in millions) | 2023 |
| 2022 | |||
Beginning balance | $ | | $ | | ||
Additions (releases) | | | ||||
Write-offs | ( | ( | ||||
Other * | ( | ( | ||||
Ending balance | $ | | $ | |
* | Primarily driven by currency effects. |
The contract assets allowance for credit losses was not material in any of the periods presented.
Major Clients
Deferred Costs
Costs to acquire and fulfill customer contracts are deferred and amortized over the contract period or expected customer relationship life. The expected customer relationship period is determined based on the average customer relationship period, including expected renewals, for each offering type and ranges from
The following table provides amounts of capitalized costs to acquire and fulfill customer contracts at December 31, 2023 and March 31, 2023:
December 31, | March 31, | |||||
(Dollars in millions) |
| 2023 |
| 2023 | ||
Deferred transition costs | $ | | $ | | ||
Prepaid software costs |
| |
| | ||
Capitalized costs to fulfill contracts |
| |
| | ||
Capitalized costs to obtain contracts |
| |
| | ||
Total deferred costs * | $ | | $ | |
* | Of the total deferred costs, $ |
The amount of total deferred costs amortized for the three months ended December 31, 2023 was $
11
Notes to Consolidated Financial Statements (continued)
NOTE 4. SEGMENTS
Our reportable segments correspond to how the chief operating decision maker (“CODM”) reviews performance and allocates resources. Our
United States: This reportable segment is comprised of Kyndryl’s operations in the United States.
Japan: This reportable segment is comprised of Kyndryl’s operations in Japan.
Principal Markets: This reportable segment represents the aggregation of our operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain / Portugal, and the United Kingdom / Ireland.
Strategic Markets: This reportable segment is comprised of our operations in all other countries in which we operate.
The measure of segment operating performance used by Kyndryl’s CODM is adjusted EBITDA. Adjusted EBITDA is defined as net income (loss) excluding net interest expense, income taxes, depreciation and amortization (excluding depreciation of right-of-use assets and amortization of capitalized contract costs), charges related to ceasing to use leased and owned fixed assets, charges related to lease terminations, transaction-related costs and benefits, pension expenses other than pension servicing costs and multi-employer plan costs, stock-based compensation expense, workforce rebalancing charges, impairment expense, significant litigation costs, and currency impacts of highly inflationary countries. The use of revenue and adjusted EBITDA aligns with how the CODM assesses performance and allocates resources for the Company’s segments.
Our geographic markets frequently work together to sell and implement certain contracts. The resulting revenues and costs from these contracts may be apportioned among the participating geographic markets. The economic environment and its effects on the industries served by our geographic markets affect revenues and operating expenses within our geographic markets to differing degrees. Currency fluctuations also tend to affect our geographic markets differently, depending on the geographic concentrations and locations of their businesses.
The following table reflects the results of the Company’s segments:
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
(Dollars in millions) |
| 2023 |
| 2022 |
| 2023 |
| 2022 | ||||
Revenue | ||||||||||||
United States | $ | | $ | | $ | | $ | | ||||
Japan | | | | | ||||||||
Principal Markets | | | | | ||||||||
Strategic Markets | | | | | ||||||||
Total revenue | $ | | $ | | $ | | $ | | ||||
Segment adjusted EBITDA | ||||||||||||
United States | $ | | $ | | $ | | $ | | ||||
Japan | | | | | ||||||||
Principal Markets | | | | | ||||||||
Strategic Markets | | | | | ||||||||
Total segment adjusted EBITDA | $ | | $ | | $ | | $ | |
12
Notes to Consolidated Financial Statements (continued)
The following table reconciles segment adjusted EBITDA to consolidated pretax income (loss):
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
(Dollars in millions) |
| 2023 |
| 2022 |
| 2023 |
| 2022 | ||||
Segment adjusted EBITDA | $ | | $ | | $ | | $ | | ||||
Workforce rebalancing charges | ( | ( | ( | ( | ||||||||
Charges related to ceasing to use leased/fixed assets and lease terminations | ( | ( | ( | ( | ||||||||
Transaction-related (costs) benefits | | ( | ( | ( | ||||||||
Stock-based compensation expense | ( | ( | ( | ( | ||||||||
Interest expense | ( | ( | ( | ( | ||||||||
Depreciation of property, equipment and capitalized software | ( | ( | ( | ( | ||||||||
Amortization expense | ( | ( | ( | ( | ||||||||
Corporate expense not allocated to the segments | ( | ( | ( | ( | ||||||||
Other adjustments* | ( | ( | ( | ( | ||||||||
Pretax income (loss) | $ | | $ | ( | $ | ( | $ | ( |
* | Other adjustments represent pension expenses other than pension servicing costs and multi-employer plan costs, significant litigation costs, currency impacts of highly inflationary countries, and an adjustment to reduce amortization expense for the amount already included in transaction-related (costs) benefits above. |
NOTE 5. TAXES
For the three months ended December 31, 2023, the Company’s effective tax rate was
The Company’s effective tax rate for the three months ended December 31, 2023 was higher than the Company’s statutory tax rate primarily due to taxes on foreign operations, uncertain tax positions and valuation allowances recorded in certain jurisdictions against deferred tax assets that are not more likely than not to be realized. The Company’s effective tax rate for the nine months ended December 31, 2023 was lower than the Company’s statutory tax rate primarily due to taxes on foreign operations and valuation allowances recorded in certain jurisdictions against deferred tax assets that are not more likely than not to be realized.
The Company’s effective tax rate for the three months ended December 31, 2022 differed from the Company’s statutory tax rate primarily due to a benefit recorded during the period resulting from return-to-provision adjustments related to the filing of certain income tax returns. The Company’s effective tax rate for the nine months ended December 31, 2022 was lower than the Company’s statutory tax rate primarily due to taxes on foreign operations and an increase in valuation allowances in certain jurisdictions against deferred tax assets that are not more likely than not to be realized, partially offset by the benefit resulting from return-to-provision adjustments.
13
Notes to Consolidated Financial Statements (continued)
NOTE 6. NET LOSS PER SHARE
We did
|
| |||||||||||
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
(In millions, except per share amounts) | 2023 | 2022 | 2023 | 2022 | ||||||||
Net income (loss) on which basic and diluted earnings per share is calculated | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Number of shares on which basic and diluted earnings per share is calculated | | | | | ||||||||
Basic earnings (loss) per share | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Diluted earnings (loss) per share |
| ( | ( |
| ( | ( |
For the three and nine months ended December 31, 2023 and 2022, the Company’s basic and diluted weighted-average shares outstanding were the same. The following securities were not included in the computation of diluted earnings (loss) per share because they would have been anti-dilutive:
December 31, | ||||
(In millions) | 2023 | 2022 | ||
Nonvested restricted stock units | | | ||
Nonvested performance-conditioned stock units | | | ||
Nonvested market-conditioned stock units | | | ||
Stock options issued and outstanding | | | ||
Total | | |
NOTE 7. FINANCIAL ASSETS AND LIABILITIES
Fair Value Measurements
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company classifies certain assets and liabilities based on the following fair value hierarchy:
● | Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that can be accessed at the measurement date. |
● | Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. |
● | Level 3 – Unobservable inputs for the asset or liability. |
The level of an asset or liability within the fair value hierarchy is determined based on the lowest level of any input that is significant to the fair value measurement.
In determining the fair value of certain financial instruments, the Company considers certain market valuation adjustments to the “base valuations” using the methodologies described below for several parameters that market participants would consider in determining fair value:
14
Notes to Consolidated Financial Statements (continued)
● | Counterparty credit risk adjustments are applied to certain financial instruments, taking into account the actual credit risk of a counterparty as observed in the credit default swap market to determine the true fair value of such an instrument. |
● | Credit risk adjustments are applied to reflect the Company’s own credit risk when valuing certain liabilities measured at fair value. The methodology is consistent with that applied in developing counterparty credit risk adjustments, but incorporates the Company’s credit risk as observed in the credit default swap market. |
Certain non-financial assets such as property, plant and equipment, operating right-of-use assets, land, goodwill and intangible assets are recorded at fair value or at cost, as appropriate, in the period they are initially recognized, and such balances may be adjusted in subsequent periods if an event occurs or circumstances change that indicate that the asset may be impaired. The impairment models used for non-financial assets depend on the type of asset. The fair value measurements, in such instances, would be classified in Level 3 of the fair value hierarchy.
We perform a qualitative assessment of asset impairments on a periodic basis and recognize an impairment if there are sufficient indicators that the fair value is less than carrying value. There were
Financial Assets and Liabilities Measured at Fair Value
The following table presents the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis at December 31, 2023 and March 31, 2023:
Fair Value | ||||||||||||||||||||
Hierarchy | At December 31, 2023 | At March 31, 2023 | ||||||||||||||||||
(Dollars in millions) |
| Level |
| Assets |
| Liabilities |
| Fair Value |
| Assets |
| Liabilities |
| Fair Value | ||||||
Derivatives designated as hedging instruments: | ||||||||||||||||||||
Foreign exchange contracts | 2 | $ | | $ | | $ | | $ | | $ | | $ | | |||||||
Derivatives not designated as hedging instruments: | ||||||||||||||||||||
Foreign exchange contracts | 2 | | | | | | | |||||||||||||
Total | $ | | $ | | $ | | $ | | $ | | $ | |
The gross balances of derivative assets are contained within prepaid expenses and other current assets, and the gross balances of derivative liabilities are contained within other accrued expenses and liabilities in the Consolidated Balance Sheet. The Company may enter into master netting agreements with certain counterparties that allow for netting of exposures. There was
Financial Assets and Liabilities Not Measured at Fair Value
Accounts receivable are financial assets with carrying values that approximate fair value. Accounts payable, other accrued expenses and short-term debt are financial liabilities with carrying values that approximate fair value. If measured at fair value in the consolidated financial statements, these financial assets and liabilities would be classified as Level 3 in the fair value hierarchy, except for short-term debt, which would be classified as Level 2.
The Company also has time deposits that have maturities of 90 days or less, and their carrying values approximate fair value. They are measured for impairment on a recurring basis by comparing their fair value with their amortized cost basis. There were
15
Notes to Consolidated Financial Statements (continued)
balances of these time deposits with maturities of 90 days or less contained within cash and cash equivalents in the Consolidated Balance Sheet at December 31, 2023 and March 31, 2023 were $
The fair value of our outstanding debt (excluding finance lease obligations) is based on various methodologies, including quoted prices in active markets for identical debt instruments, which is a Level 1 measurement, and calculated fair value using an expected present value technique that uses rates currently available to the Company for debt in active markets with similar terms and remaining maturities, which is a Level 2 measurement. Our outstanding debt (excluding finance lease obligations) had a carrying value of $
Transfers of Financial Assets
The Company has entered into agreements with third-party financial institutions to sell certain financial assets (primarily trade receivables) without recourse. The Company has determined these are true sales. The carrying value of the financial asset sold is derecognized, and a net gain or loss on the sale is recognized at the time of the transfer.
The net proceeds from these agreements are reflected as cash provided by operating activities in the Consolidated Statement of Cash Flows. Gross proceeds from receivables sold to third parties under this program were $
Derivative Financial Instruments
Derivatives Designated as Hedging Instruments
The Company has foreign exchange derivative financial instruments designated as cash flow hedges to manage the volatility of cash flows that relate to operating expenses denominated in certain currencies. Changes in fair value of derivatives designated as cash flow hedges are recorded, net of applicable taxes, in other comprehensive income and subsequently reclassified into the same income statement line item as the hedged exposure when the underlying hedged item is recognized in earnings. The cash flows associated with derivatives designated as cash flow hedges are reported in cash flows from operating activities in the Consolidated Statement of Cash Flows.
At December 31, 2023 and March 31, 2023, the total gross notional amount of foreign exchange contracts designated as cash flow hedges of forecasted foreign currency cost transactions was $
At December 31, 2023 and March 31, 2023, in connection with cash flow hedges of foreign currency cost transactions, the Company had net deferred gains of $
16
Notes to Consolidated Financial Statements (continued)
Derivatives Not Designated as Hedging Instruments
The Company enters into currency forward and swap contracts to hedge exposures related to assets, liabilities and earnings across its subsidiaries. These contracts are not designated as hedging instruments, and therefore changes in fair value of these contracts are reported in earnings in other expense (income) in the Consolidated Income Statement. The gains and losses on these contracts generally offset the gains and losses in the underlying hedged exposures, which are also reported in other expense (income) in the Consolidated Income Statement. Cash flows from derivatives not designated as hedges are reported in cash flows from investing activities in the Consolidated Statement of Cash Flows. The terms of these swap contracts are generally less than
The Effect of Derivative Instruments in the Consolidated Income Statement
The effects of derivatives designated as hedging instruments on the Consolidated Income Statement and Other Comprehensive Income are as follows:
Unrealized Gain (Loss) | Consolidated | Gain (Loss) Reclassified | ||||||||||||
(Dollars in millions) | Recognized in OCI | Income Statement | from AOCI to Income | |||||||||||
Three months ended December 31: |
| 2023 |
| 2022 |
| Line Item |
| 2023 |
| 2022 | ||||
Foreign exchange contracts | $ | ( | $ | ( | $ | | $ | ( | ||||||
Total | $ | ( | $ | ( |
| $ | | $ | ( |
Unrealized Gain (Loss) | Consolidated | Gain (Loss) | ||||||||||||
(Dollars in millions) | Recognized in OCI | Income Statement | Reclassified from AOCI | |||||||||||
Nine months ended December 31: |
| 2023 |
| 2022 |
| Line Item |
| 2023 |
| 2022 | ||||
Foreign exchange contracts | $ | $ | ( | $ | $ | ( | ||||||||
Total | $ | | $ | ( |
| $ | | $ | ( |
For the three and nine months ended December 31, 2023 and 2022, there were
The effects of derivatives not designated as hedging instruments on the Consolidated Income Statement are as follows:
Consolidated | Gain (Loss) | |||||||
(Dollars in millions) | Income Statement | Recognized on Derivatives | ||||||
Three months ended December 31: |
| Line Item | 2023 |
| 2022 | |||
Foreign exchange contracts | $ | | $ | | ||||
Total |
| $ | | $ | |
Consolidated | Gain (Loss) | |||||||
(Dollars in millions) | Income Statement | Recognized on Derivatives | ||||||
Nine months ended December 31: |
| Line Item | 2023 |
| 2022 | |||
Foreign exchange contracts | $ | ( | $ | | ||||
Total |
| $ | ( | $ | |
17
Notes to Consolidated Financial Statements (continued)
NOTE 8. INTANGIBLE ASSETS INCLUDING GOODWILL
Intangible Assets
The following table presents the Company’s intangible asset balances by major asset class.
At December 31, 2023 | At March 31, 2023 | |||||||||||||||||
| Gross Carrying |
| Accumulated |
| Net Carrying |
| Gross Carrying |
| Accumulated |
| Net Carrying | |||||||
(Dollars in millions) |
| Amount |
| Amortization |
| Amount |
| Amount |
| Amortization |
| Amount | ||||||
Capitalized software | $ | | $ | ( | $ | | $ | | $ | ( | $ | | ||||||
Customer relationships* | | ( | | |
| ( |
| | ||||||||||
Completed technology |
| |
| ( |
| — |
| |
| ( |
| — | ||||||
Patents and trademarks* |
| |
| ( |
| |
| |
| ( |
| | ||||||
Total | $ | | $ | ( | $ | | $ | | $ | ( | $ | |
* Amounts include effects from currency translation.
The net carrying amount of intangible assets increased by $
The future amortization expense relating to intangible assets currently recorded in the Consolidated Balance Sheet was estimated to be the following at December 31, 2023:
Capitalized | Customer | Patents and | ||||||||||
(Dollars in millions) | Software |
| Relationships | Trademarks | Total | |||||||
Year ending March 31: | ||||||||||||
2024 (remaining three months) | $ | | $ | $ | $ | |||||||
2025 | |
| ||||||||||
2026 | |
| ||||||||||
2027 | |
| ||||||||||
2028 | — | — |
| |||||||||
Thereafter | — | | — |
| |
18
Notes to Consolidated Financial Statements (continued)
Goodwill
The changes in the goodwill balances by segment for the nine months ended December 31, 2023 were as follows:
Additions and | |||||||||
(Dollars in millions) | Balance at | Other | Balance at | ||||||
Segment | March 31, 2023 | Adjustments* |
| December 31, 2023 | |||||
United States | $ | — | $ | — | $ | — | |||
Japan | | ( | | ||||||
Principal Markets |
| |
| — | | ||||
Strategic Markets |
| |
| — | | ||||
Total | $ | | $ | ( | $ | |
* Primarily driven by foreign currency translation.
There were
NOTE 9. BORROWINGS
Debt
The following table presents the components of our debt:
|
| December 31, | March 31, | |||||||
(Dollars in millions) | Interest Rate | Maturity | 2023 | 2023 | ||||||
Unsecured floating-rate term loan | November 2024 | $ | | $ | | |||||
Commercial loan agreement | July 2026 | | | |||||||
Unsecured senior notes due 2026 | October 2026 | | | |||||||
Unsecured senior notes due 2028 | October 2028 | | | |||||||
Unsecured senior notes due 2031 | October 2031 | | | |||||||
Unsecured senior notes due 2041 | October 2041 | | | |||||||
Finance lease obligations | 2024-2028 | | | |||||||
$ | | $ | | |||||||
Less: Unamortized discount | | | ||||||||
Less: Unamortized debt issuance costs |
|
| | | ||||||
Less: Current portion of debt |
|
| | | ||||||
Total long-term debt |
|
| $ | | $ | |
* Floating rate calculated as of December 31, 2023, using a rate equal to one-month SOFR plus
** Represents the weighted-average interest rate.
19
Notes to Consolidated Financial Statements (continued)
Contractual obligations of long-term debt outstanding at December 31, 2023, exclusive of finance lease obligations, are as follows:
(Dollars in millions)* |
| Principal | |
Year ending March 31: | |||
2024 (remaining three months) | $ | | |
2025 |
| | |
2026 |
| | |
2027 |
| | |
2028 | — | ||
Thereafter |
| | |
Total | $ | |
* Contractual obligations approximate scheduled repayments.
During the three and nine months ended December 31, 2023, the right-of-use assets obtained in exchange for new finance lease liabilities were $
As of December 31, 2023, there were
NOTE 10. COMMITMENTS AND CONTINGENCIES
The Company guarantees certain loans and financial commitments. The maximum potential future payment under these financial guarantees and the fair value of these guarantees recognized in the Consolidated Balance Sheet at December 31, 2023 and March 31, 2023 were not material. Additionally, the Company has contractual commitments that are noncancellable with certain software, hardware and cloud partners used in the delivery of services to customers. During the three and nine months ended December 31, 2023, contractual commitments decreased due to satisfaction of existing commitments outpacing new additions.
As a company with approximately
The Company records a provision with respect to a claim, suit, investigation or proceeding when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. In accordance with the relevant accounting guidance, the Company provides disclosures of matters for which the likelihood of material loss is at least
20
Notes to Consolidated Financial Statements (continued)
reasonably possible. In addition, the Company may also disclose matters based on its consideration of other matters and qualitative factors.
The Company reviews claims, suits, investigations and proceedings at least quarterly, and decisions are made with respect to recording or adjusting provisions and disclosing reasonably possible losses or range of losses (individually or in the aggregate) to reflect the impact and status of settlement discussions, discovery, procedural and substantive rulings, reviews by counsel and other information pertinent to a particular matter.
Whether any losses, damages or remedies finally determined in any claim, suit, investigation or proceeding could reasonably have a material effect on the Company’s business, financial condition, results of operations or cash flows will depend on a number of variables, including the timing and amount of such losses or damages; the structure and type of any such remedies; the significance of the impact any such losses, damages or remedies may have in the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors. While the Company will continue to defend itself vigorously, it is possible that the Company’s business, financial condition, results of operations or cash flows could be affected in any particular period by the resolution of one or more of these matters.
In July 2017, BMC Software, Inc. (“BMC”) filed suit against IBM in the U.S. Court for the Southern District of Texas in a dispute involving various aspects of IBM’s business, including its managed infrastructure business. BMC alleged IBM’s removal of BMC software from one of its client’s sites at the client’s request constituted breach of contract, fraudulent inducement and trade secret misappropriation. In May 2022, the trial court entered a judgment against IBM and awarded BMC $
Separately, certain contractual disputes have arisen between Kyndryl and IBM following the Separation. IBM and Kyndryl have commenced arbitration proceedings related to certain of these matters. The Company anticipates that some of these proceedings may conclude as early as the first half of calendar year 2024, while others are in preliminary stages. Kyndryl intends to vigorously pursue its interests and defenses in these matters, including asserting its own claims in arbitration if necessary.
21
Notes to Consolidated Financial Statements (continued)
NOTE 11. EQUITY
The following tables present reclassifications and taxes related to items of other comprehensive income (loss) for the three and nine months ended December 31, 2023 and 2022:
| Pretax |
| Tax (Expense) |
| Net-of-Tax | ||||
(Dollars in millions) |
| Amount |
| Benefit |
| Amount | |||
For the three months ended December 31, 2023: | |||||||||
Foreign currency translation adjustments | $ | | $ | — | $ | | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | ( | $ | | $ | — | |||
Reclassification of (gains) losses to net income | ( | — | ( | ||||||
Total unrealized gains (losses) on cash flow hedges | $ | ( | $ | | $ | ( | |||
Retirement-related benefit plans*: | |||||||||
Amortization of prior service (credits) costs | $ | — | $ | ( | $ | ( | |||
Amortization of net (gains) losses | ( | | | ||||||
Total retirement-related benefit plans | $ | ( | $ | | $ | | |||
Other comprehensive income (loss) | $ | | $ | | $ | | |||
For the three months ended December 31, 2022: | |||||||||
Foreign currency translation adjustments | $ | | $ | — | $ | | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | ( | $ | — | $ | ( | |||
Reclassification of (gains) losses to net income | | — | | ||||||
Total unrealized gains (losses) on cash flow hedges | $ | ( | $ | — | $ | ( | |||
Retirement-related benefit plans – amortization of net (gains) losses* | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | | $ | ( | $ | |
* | These AOCI components are included in the computation of net periodic benefit cost. Refer to Note 12 – Retirement-Related Benefits for additional information. |
22
Notes to Consolidated Financial Statements (continued)
| Pretax |
| Tax (Expense) |
| Net-of-Tax | ||||
(Dollars in millions) |
| Amount |
| Benefit |
| Amount | |||
For the nine months ended December 31, 2023: | |||||||||
Foreign currency translation adjustments | $ | | $ | — | $ | | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | | $ | | $ | | |||
Reclassification of (gains) losses to net income | ( | — | ( | ||||||
Total unrealized gains (losses) on cash flow hedges | $ | | $ | | $ | | |||
Retirement-related benefit plans*: | |||||||||
Amortization of prior service (credits) costs | $ | | $ | ( | $ | ( | |||
Amortization of net (gains) losses | | | | ||||||
Total retirement-related benefit plans | $ | | $ | | $ | | |||
Other comprehensive income (loss) | $ | | $ | | $ | | |||
For the nine months ended December 31, 2022: |
| ||||||||
Foreign currency translation adjustments | $ | ( | $ | — | $ | ( | |||
Unrealized gains (losses) on cash flow hedges: | |||||||||
Unrealized gains (losses) arising during the period | $ | ( | $ | | $ | ( | |||
Reclassification of (gains) losses to net income | | — | | ||||||
Total unrealized gains (losses) on cash flow hedges | $ | ( | $ | | $ | ( | |||
Retirement-related benefit plans – amortization of net (gains) losses* | $ | | $ | ( | $ | | |||
Other comprehensive income (loss) | $ | ( | $ | ( | $ | ( |
* | These AOCI components are included in the computation of net periodic benefit cost. Refer to Note 12 – Retirement-Related Benefits for additional information. |
23
Notes to Consolidated Financial Statements (continued)
The following tables present the components of accumulated other comprehensive income (loss), net of taxes:
Net Unrealized | Foreign | Net Change | Accumulated | |||||||||
Gain (Losses) | Currency | Retirement- | Other | |||||||||
on Cash | Translation | Related | Comprehensive | |||||||||
(Dollars in millions) |
| Flow Hedges | Adjustments* |
| Benefit Plans | Income (Loss) | ||||||
October 1, 2023 | $ | | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) | ( | | | | ||||||||
December 31, 2023 | $ | | $ | ( | $ | ( | $ | ( | ||||
October 1, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) | ( | | | | ||||||||
December 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( |
Net Unrealized | Foreign | Net Change | Accumulated | |||||||||
Gain (Losses) | Currency | Retirement- | Other | |||||||||
on Cash | Translation | Related | Comprehensive | |||||||||
(Dollars in millions) |
| Flow Hedges | Adjustments* |
| Benefit Plans | Income (Loss) | ||||||
April 1, 2023 | $ | — | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) | | | | | ||||||||
December 31, 2023 | $ | | $ | ( | $ | ( | $ | ( | ||||
April 1, 2022 | $ | | $ | ( | $ | ( | $ | ( | ||||
Other comprehensive income (loss) | ( | ( | | ( | ||||||||
December 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( |
* | Foreign currency translation adjustments are presented gross. |
NOTE 12. RETIREMENT-RELATED BENEFITS
The following table presents the components of net periodic pension cost for the defined benefit pension plans recognized in the Consolidated Income Statement for the three and nine months ended December 31, 2023 and 2022.
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
(Dollars in millions) |
| 2023 |
| 2022 |
| 2023 |
| 2022 | ||||
Service cost |
| $ | |
| $ | |
| $ | |
| $ | |
| |
| |
| |
| | |||||
| ( |
| ( |
| ( |
| ( | |||||
Amortization of prior service costs (credits)* |
| — |
| — |
| |
| — | ||||
| | | | |||||||||
| — | | — | |||||||||
Net periodic pension cost |
| $ | |
| $ | |
| $ | |
| $ | |
* These components of net periodic pension cost are included in other expense (income) in the Consolidated Income Statement.
The components of net periodic benefit cost for the nonpension postretirement benefit plans and multi-employer plans recognized in the Consolidated Income Statement were not material for the periods presented.
24
Notes to Consolidated Financial Statements (continued)
NOTE 13. TRANSACTIONS WITH FORMER PARENT
Change in Beneficial Ownership
IBM ceased to be a related party of Kyndryl in August 2022 after IBM transferred all of its
Revenue and Purchases Related to Former Parent
Kyndryl provides various services to IBM, including those related to hosting data centers and servicing IBM’s information technology infrastructure, which are reported as revenue in the Company’s Consolidated Income Statement. Related-party revenue generated from these services was $
Kyndryl utilizes various IBM products and services, recognized as costs of services, in the fulfillment of services contracts. Total cost of services recognized from these related-party transactions in the Company’s Consolidated Income Statement was $
Capital expenditures for purchases of IBM hardware were reflected as related-party payments for property and equipment within the investing section of the Company’s Consolidated Statement of Cash Flows in the amount of $
NOTE 14. WORKFORCE REBALANCING AND SITE-RATIONALIZATION CHARGES
During the fiscal year ended March 31, 2023, the Company initiated actions to reduce our overall cost structure and increase our operating efficiency. These actions are anticipated to occur over several quarters and result in workforce rebalancing charges, charges related to ceasing to use leased and owned fixed assets, and lease termination charges (collectively, the “charges”). We expect the total charges to be incurred for this program to be approximately $
25
Notes to Consolidated Financial Statements (continued)
The following table presents the segment breakout of charges incurred during the three and nine months ended December 31, 2023 and during the full length of the program.
Three Months Ended | Nine Months Ended | Costs Incurred | |||||||
(Dollars in millions) |
| December 31, 2023 |
| December 31, 2023 | to Date | ||||
United States | $ | | $ | | $ | | |||
Japan | — | | | ||||||
Principal Markets | | | | ||||||
Strategic Markets | | | | ||||||
Corporate charges not allocated to the segments | — | | | ||||||
Total charges | $ | | $ | | $ | |
The following table presents the classification of workforce rebalancing and site-rationalization activities in the Consolidated Income Statement during the three and nine months ended December 31, 2023 and during the full length of the program. Charges in the three and nine months ended December 31, 2022 were immaterial.
Three Months Ended | Nine Months Ended | Costs Incurred | |||||||
(Dollars in millions) |
| December 31, 2023 |
| December 31, 2023 |
| to Date | |||
Cost of services | $ | | $ | | $ | | |||
Selling, general and administrative expenses | | | | ||||||
Workforce rebalancing charges | | | | ||||||
Total charges | $ | | $ | | $ | |
The following table presents the components of and changes in our workforce rebalancing and site-rationalization charges liabilities during the nine months ended December 31, 2023.
Liabilities | Liabilities | Liabilities | |||||||||||||
Workforce | Related to | Related to | Related to | ||||||||||||
Rebalancing | Ceasing to Use | Lease | Ceasing to Use | ||||||||||||
(Dollars in millions) |
| Liabilities* | Leased Assets | Terminations | Fixed Assets | Total | |||||||||
Balance at March 31, 2023 | $ | | $ | — | $ | | $ | — | $ | | |||||
Charges / (benefits) | | | ( | | | ||||||||||
Cash payments | ( | — | ( | ( | ( | ||||||||||
Non-cash adjustments | ( | ( | — | ( | ( | ||||||||||
Balance at December 31, 2023 | $ | | $ | — | $ | — | $ | — | $ | |
* | Excludes historical workforce rebalancing liabilities of $ |
26
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FOR THE THREE AND NINE MONTHS ENDED DECEMBER 31, 2023
Overview
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 | ||||||||||
Revenue | $ | 3,936 | $ | 4,303 | $ | 12,202 | $ | 12,771 | ||||||||
Revenue growth (GAAP) | (9) | % | (6) | % | (4) | % | (8) | % | ||||||||
Revenue growth in constant currency(1) | (10) | % |
| 3 | % | (5) | % |
| 0 | % | ||||||
Net income (loss) | $ | (12) | $ | (106) | $ | (295) | $ | (637) | ||||||||
Adjusted EBITDA(1) | $ | 615 | $ | 580 | $ | 1,801 | $ | 1,499 |
(1) Revenue growth in constant currency and adjusted EBITDA are non-GAAP financial metrics. For definitions of these metrics and a reconciliation of adjusted EBITDA to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, see “Segment Results” below.
| December 31, | March 31, | ||||
(Dollars in millions) |
| 2023 |
| 2023 | ||
Assets | $ | 10,969 | $ | 11,464 | ||
Liabilities | 9,676 | 10,002 | ||||
Equity | 1,293 | 1,462 |
Organization of Information
Kyndryl Holdings, Inc. was formed as a wholly-owned subsidiary of IBM in September 2021 to hold the operations of the infrastructure services unit of IBM’s Global Technology Services segment. On November 3, 2021, Kyndryl separated from IBM through a spin-off that was tax-free for U.S. federal tax purposes. Following the Separation, Kyndryl became an independent, publicly-traded company and the world’s leading IT infrastructure services provider.
Financial Performance Summary
Macro Dynamics
In fiscal year 2024, we have seen continuing demand for information technology services, despite concerns about economic growth, increased geopolitical tensions, inflationary pressures and government efforts to stem inflation. Although government efforts to stem inflation are expected to suppress economic growth, most economists, including the International Monetary Fund, continue to expect positive global macroeconomic growth in calendar year 2024.
Financial Performance
For the three months ended December 31, 2023, we reported $3.9 billion in revenue, a decline of 9 percent compared to the three months ended December 31, 2022. The revenue decline was largely attributable to actions the Company has taken to reduce unprofitable and low-margin components of its customer relationships. United States revenue declined 18 percent, Japan revenue declined 4 percent, Principal Markets revenue declined 2 percent and Strategic Markets revenue decreased 9 percent, compared to the three months ended December 31, 2022. Net loss of $12 million improved by $94 million versus the prior-year period driven by progress on our key initiatives to drive operating efficiencies, increased margins and the impact of an agreement to collect previously reserved receivables from our former Parent.
27
Management Discussion (continued)
For the nine months ended December 31, 2023, we reported $12.2 billion in revenue, a decline of 4 percent compared to the nine months ended December 31, 2022. The revenue decline was largely attributable to actions the Company has taken to reduce unprofitable and low-margin components of its customer relationships. United States revenue declined 8 percent, Japan revenue declined 5 percent, Principal Markets revenue declined 1 percent and Strategic Markets revenue decreased 5 percent, compared to the nine months ended December 31, 2022. Net loss of $295 million improved by $342 million versus the prior-year period driven by progress on our key initiatives to drive operating efficiencies, increased margins and the impact of an agreement to collect previously reserved receivables from our former Parent.
Segment Results
The following table presents our reportable segments’ revenue and adjusted EBITDA for the three and nine months ended December 31, 2023 and 2022. Segment revenue and revenue growth in constant currency exclude any transactions between the segments.
Three Months Ended December 31, | Year-over-Year Change | Nine Months Ended December 31, | Year-over-Year Change | |||||||||||||||||||
(Dollars in millions) |
| 2023 | 2022 | 2023 vs. 2022 |
| 2023 | 2022 | 2023 vs. 2022 | ||||||||||||||
Revenue | ||||||||||||||||||||||
United States | $ | 1,032 | $ | 1,265 | (18) | % | $ | 3,305 | $ | 3,581 | (8) | % | ||||||||||
Japan | 581 | 606 | (4) | % | 1,761 | 1,855 | (5) | % | ||||||||||||||
Principal Markets | 1,446 | 1,472 | (2) | % | 4,395 | 4,460 | (1) | % | ||||||||||||||
Strategic Markets | 877 | 961 | (9) | % | 2,741 | 2,874 | (5) | % | ||||||||||||||
Total revenue | $ | 3,936 | $ | 4,303 | (9) | % | $ | 12,202 | $ | 12,771 | (4) | % | ||||||||||
Revenue growth in constant currency(1) | (10) | % | 3 | % | (5) | % | 0 | % | ||||||||||||||
Adjusted EBITDA(1) | ||||||||||||||||||||||
United States | $ | 194 | $ | 271 | (28) | % | $ | 607 | $ | 639 | (5) | % | ||||||||||
Japan | 94 | 90 | 5 | % | 278 | 318 | (12) | % | ||||||||||||||
Principal Markets | 207 | 91 | 128 | % | 560 | 248 | 126 | % | ||||||||||||||
Strategic Markets | 144 | 145 | (0) | % | 428 | 352 | 21 | % | ||||||||||||||
Corporate and other(2) | (25) | (16) | NM | (71) | (57) | NM | ||||||||||||||||
Total adjusted EBITDA(1) | $ | 615 | $ | 580 | 6 | % | $ | 1,801 | $ | 1,499 | 20 | % |
NM – not meaningful
(1) | Revenue growth in constant currency and adjusted EBITDA are non-GAAP financial metrics. See the information below for definitions of these metrics and a reconciliation of adjusted EBITDA to net income (loss). |
(2) | Represents net amounts not allocated to segments. |
We report our financial results in accordance with U.S. GAAP. We also present certain non-GAAP financial measures to provide useful supplemental information to investors. We provide these non-GAAP financial measures as we believe it enhances visibility to underlying results and the impact of management decisions on operational performance and enables better comparison to peer companies.
Revenue growth in constant currency is a non-GAAP measure that eliminates the effects of exchange rate fluctuations when translating from foreign currencies to the United States dollar. It is calculated by using the average exchange rates that existed for the same period of the prior year. Constant-currency measures are provided so that revenue can be viewed without the effect of fluctuations in currency exchange rates, which is consistent with how management evaluates our revenue results and trends.
Additionally, management uses adjusted EBITDA to evaluate our performance. Adjusted EBITDA is a non-GAAP measure and defined as net income (loss) excluding net interest expense, income taxes, depreciation and
28
Management Discussion (continued)
amortization (excluding depreciation of right-of-use assets and amortization of capitalized contract costs), charges related to ceasing to use leased/fixed assets, charges related to lease terminations, transaction-related costs and benefits, pension expenses other than pension servicing costs and multi-employer plan costs, stock-based compensation expense, workforce rebalancing charges, impairment expense, significant litigation costs and currency impacts of highly inflationary countries. We believe that adjusted EBITDA is a helpful supplemental measure to assist investors in evaluating our operating results as it excludes certain items whose fluctuation from period to period does not necessarily correspond to changes in the operations of our business. We provide this non-GAAP financial measure as we believe it enhances visibility to underlying results and the impact of management decisions on operational performance, enables better comparison to peer companies and allows us to provide a long-term strategic view of the business.
These disclosures are provided in addition to and not as a substitute for the percentage change in revenue and profit or loss measures on a U.S. GAAP basis compared to the corresponding period in the prior year. Other companies may calculate and define similarly labeled items differently, which may limit the usefulness of this measure for comparative purposes.
The following table provides a reconciliation of U.S. GAAP net income (loss) to adjusted EBITDA:
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||
(Dollars in millions) |
| 2023 |
| 2022 |
| 2023 |
| 2022 | ||||
Net income (loss) | $ | (12) | $ | (106) | $ | (295) | $ | (637) | ||||
Provision for (benefit from) income taxes | 65 | (32) | 131 | 74 | ||||||||
Workforce rebalancing charges | 19 | 10 | 115 | 16 | ||||||||
Charges related to ceasing to use leased/fixed assets and lease terminations | 14 | 10 | 24 | 10 | ||||||||
Transaction-related costs (benefits) | (77) | 48 | 12 | 218 | ||||||||
Stock-based compensation expense | 25 | 29 | 72 | 81 | ||||||||
Interest expense | 31 | 27 | 92 | 65 | ||||||||
Depreciation of property, equipment and capitalized software | 207 | 232 | 639 | 681 | ||||||||
Amortization expense | 322 | 336 | 968 | 945 | ||||||||
Other adjustments* | 21 | 27 | 42 | 45 | ||||||||
Adjusted EBITDA (non-GAAP) | $ | 615 | $ | 580 | $ | 1,801 | $ | 1,499 |
* | Other adjustments represent pension expenses other than pension servicing costs and multi-employer plan costs, significant litigation costs, currency impacts of highly inflationary countries, and an adjustment to reduce amortization expense for the amount already included in transaction-related costs (benefits) above. |
United States
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 | ||||||||||
Revenue | $ | 1,032 | $ | 1,265 | $ | 3,305 | $ | 3,581 | ||||||||
Revenue year-over-year change | (18) | % | 6 | % | (8) | % | 0 | % | ||||||||
Adjusted EBITDA | $ | 194 | $ | 271 | $ | 607 | $ | 639 | ||||||||
Adjusted EBITDA year-over-year change | (28) | % | (5) | % |
For the three months ended December 31, 2023, United States revenue of $1.0 billion decreased 18 percent compared to the prior-year quarter, driven by the Company’s efforts to reduce certain low-margin revenues and lower revenue from contracts with minimum annual revenue commitments. Adjusted EBITDA decreased $77 million from the prior-year quarter, primarily driven by lower revenue from contracts with minimum annual revenue commitments and an increase in software costs of $16 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
29
Management Discussion (continued)
For the nine months ended December 31, 2023, United States revenue of $3.3 billion decreased 8 percent compared to the nine months ended December 31, 2022, driven by the Company’s efforts to reduce certain low-margin revenues. Adjusted EBITDA decreased $32 million from the prior-year period, primarily driven by an increase in software costs of $48 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments, partially offset by increased operating efficiencies and higher margins on recent signings.
Japan
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 | ||||||||||
Revenue | $ | 581 | $ | 606 | $ | 1,761 | $ | 1,855 | ||||||||
Revenue year-over-year change | (4) | % | (11) | % | (5) | % | (14) | % | ||||||||
Revenue growth in constant currency | 0 | % | 10 | % | (1) | % | 5 | % | ||||||||
Adjusted EBITDA | $ | 94 | $ | 90 | $ | 278 | $ | 318 | ||||||||
Adjusted EBITDA year-over-year change | 5 | % | (12) | % |
For the three months ended December 31, 2023, Japan revenue of $581 million decreased 4 percent compared to the prior-year quarter, driven by an unfavorable currency exchange rate impact of four points. Adjusted EBITDA increased $4 million from the prior-year quarter, due to a decrease in software costs of $3 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
For the nine months ended December 31, 2023, Japan revenue of $1.8 billion decreased 5 percent compared to the nine months ended December 31, 2022, driven primarily by an unfavorable currency exchange rate impact of four points. Adjusted EBITDA decreased $40 million from the prior-year period, primarily driven by unfavorable currency movements that impacted both non-yen-denominated costs and the translation of earnings into U.S. dollars.
Principal Markets
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 | ||||||||||
Revenue | $ | 1,446 | $ | 1,472 | $ | 4,395 | $ | 4,460 | ||||||||
Revenue year-over-year change | (2) | % | (12) | % | (1) | % | (15) | % | ||||||||
Revenue growth in constant currency | (5) | % | (2) | % | (4) | % | (5) | % | ||||||||
Adjusted EBITDA | $ | 207 | $ | 91 | $ | 560 | $ | 248 | ||||||||
Adjusted EBITDA year-over-year change | 128 | % | 126 | % |
For the three months ended December 31, 2023, Principal Markets revenue of $1.4 billion decreased 2 percent compared to the prior-year quarter, including a favorable currency exchange rate impact of three points. The revenue decline was largely attributable to actions the Company has taken to reduce low-margin components of its customers relationships. Adjusted EBITDA increased $116 million from the prior-year quarter, primarily due to increased operating efficiencies, higher margins on recent signings and a decrease in software costs of $20 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
For the nine months ended December 31, 2023, Principal Markets revenue of $4.4 billion decreased 1 percent compared to the nine months ended December 31, 2022, including a favorable currency exchange rate impact of three points. The revenue decline was largely attributable to actions the Company has taken to reduce low-margin components of its customer relationships. Adjusted EBITDA increased $312 million from the prior-year period, primarily due to increased operating efficiencies, higher margins on recent signings and a decrease in software costs of $59 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
30
Management Discussion (continued)
Strategic Markets
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 | ||||||||||
Revenue | $ | 877 | $ | 961 | $ | 2,741 | $ | 2,874 | ||||||||
Revenue year-over-year change | (9) | % | (5) | % | (5) | % | (1) | % | ||||||||
Revenue growth in constant currency | (13) | % | 2 | % | (8) | % | 7 | % | ||||||||
Adjusted EBITDA | $ | 144 | $ | 145 | $ | 428 | $ | 352 | ||||||||
Adjusted EBITDA year-over-year change | (0) | % | 21 | % |
For the three months ended December 31, 2023, Strategic Markets revenue of $877 million decreased 9 percent compared to the prior-year quarter, including a favorable currency exchange rate impact of four points. The revenue decline was largely attributable to actions the Company has taken to reduce low-margin components of its customer relationships. Adjusted EBITDA was largely unchanged from the prior-year quarter, due to increased operating efficiencies and higher margins on recent signings, offset by an increase in software costs of $7 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
For the nine months ended December 31, 2023, Strategic Markets revenue of $2.7 billion decreased 5 percent compared to the nine months ended December 31, 2022, including a favorable currency exchange rate impact of three points. The revenue decline was largely attributable to actions the Company has taken to reduce low-margin components of its customer relationships. Adjusted EBITDA increased $76 million from the prior-year period, primarily due to increased operating efficiencies and higher margins on recent signings, partially offset by an increase in software costs of $20 million resulting from an amendment of the contract with a software provider that re-allocated costs among our segments.
Corporate and Other
Corporate and other had an adjusted EBITDA loss of $25 million in the three months ended December 31, 2023, compared to a loss of $16 million in the three months ended December 31, 2022. Corporate and other had an adjusted EBITDA loss of $71 million in the nine months ended December 31, 2023, compared to a loss of $57 million in the nine months ended December 31, 2022.
Costs and Expenses
Three Months Ended December 31, | Percent of Revenue | Change | |||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 |
| 2023 vs. 2022 | |||||||
Revenue | $ | 3,936 | $ | 4,303 | 100.0 | % | 100.0 | % | (9) | % | |||||
Cost of services | 3,184 | 3,596 | 80.9 | % | 83.6 | % |
| (11) | % | ||||||
Selling, general and administrative expenses | 705 | 731 | 17.9 | % | 17.0 | % |
| (4) | % | ||||||
Workforce rebalancing charges |
| 19 |
| 10 |
| 0.5 | % | 0.2 | % |
| 94 | % | |||
Transaction-related costs (benefits) | (77) | 48 | (2.0) | % | 1.1 | % | NM | ||||||||
Interest expense |
| 31 |
| 27 |
| 0.8 | % | 0.6 | % |
| 16 | % | |||
Other expense |
| 21 |
| 30 |
| 0.5 | % | 0.7 | % |
| (30) | % | |||
Income (loss) before income taxes | $ | 53 | $ | (138) |
|
|
|
|
NM – not meaningful
Cost of services was 80.9% of revenue in the three months ended December 31, 2023, compared to 83.6% in the three months ended December 31, 2022, driven by increased operating efficiencies, higher margins on recent signings, and actions the Company has taken to reduce low-margin components of its customer relationships. Selling, general and administrative expenses were 17.9% of revenue in the three months ended December 31, 2023 compared to 17.0% in the prior-year quarter, driven by lower revenue, partially offset by reduced expenses. Workforce rebalancing
31
Management Discussion (continued)
charges were 0.5% of revenue in the three months ended December 31, 2023 versus 0.2% of revenue in the prior-year quarter, due to workforce rebalancing actions taken in the third quarter of fiscal 2024. Transaction-related costs (benefits) were (2.0)% of revenue in the three months ended December 31, 2023 compared to 1.1% in the prior-year quarter, driven by the impact of an agreement to collect previously reserved receivables from our former Parent. Interest expense was 0.8% of revenue in the three months ended December 31, 2023 compared to 0.6% in the prior-year quarter.
Nine Months Ended December 31, | Percent of Revenue | Change | |||||||||||||
(Dollars in millions) |
| 2023 | 2022 |
| 2023 | 2022 |
| 2023 vs. 2022 | |||||||
Revenue | $ | 12,202 | $ | 12,771 | 100.0 | % | 100.0 | % | (4) | % | |||||
Cost of services | 10,055 | 10,886 | 82.4 | % | 85.2 | % |
| (8) | % | ||||||
Selling, general and administrative expenses | 2,059 | 2,131 | 16.9 | % | 16.7 | % |
| (3) | % | ||||||
Workforce rebalancing charges |
| 115 |
| 16 |
| 0.9 | % | 0.1 | % |
| NM | ||||
Transaction-related costs | 12 | 218 | 0.1 | % | 1.7 | % | (94) | % | |||||||
Interest expense |
| 92 |
| 65 |
| 0.8 | % | 0.5 | % |
| 41 | % | |||
Other expense |
| 34 |
| 16 |
| 0.3 | % | 0.1 | % |
| 104 | % | |||
Income (loss) before income taxes | $ | (165) | $ | (563) |
|
|
|
NM – not meaningful
Cost of services was 82.4% of revenue in the nine months ended December 31, 2023, compared to 85.2% in the nine months ended December 31, 2022, driven by increased operating efficiencies, higher margins on recent signings and actions the Company has taken to reduce low-margin components of its customer relationships. Selling, general and administrative expenses were 16.9% of revenue in the nine months ended December 31, 2023 compared to 16.7% in the nine months ended December 31, 2022, driven by lower revenue, partially offset by reduced expenses. Workforce rebalancing charges were 0.9% of revenue in the nine months ended December 31, 2023 versus 0.1% of revenue in the prior-year period, due to workforce rebalancing actions taken in the first nine months of fiscal 2024. Transaction-related costs were 0.1% of revenue in the nine months ended December 31, 2023 compared to 1.7% in the prior-year period, driven by reduced rebranding and employee-retention costs and the favorable impact of an agreement to collect previously reserved receivables from our former Parent. Interest expense was 0.8% of revenue in the nine months ended December 31, 2023 compared to 0.5% in the prior-year period.
Stock-Based Compensation
In the nine months ended December 31, 2023, the Company granted equity awards to employees. These awards included 2.8 million restricted stock units that will vest ratably over four years; 2.0 million performance-conditioned stock units that are based on the attainment of operational milestones; and 0.6 million market-conditioned performance stock units that are based on the performance of the Company’s stock relative to that of its peers. Both types of performance-based awards will cliff vest based on the extent to which the performance criteria have been achieved as soon as practicable following the completion of the performance period on March 31, 2026. The total grant date fair value of the RSUs was determined using the stock price at the grant date and will be recognized as stock-based compensation expense on a straight-line basis net of actual forfeitures over the vesting period. The fair value of the performance-conditioned performance stock units ($13.37 per unit) was determined using the stock price at the grant date and will be adjusted and recognized as stock-based compensation expense based upon the probability of achievement of performance targets at each reporting period over the vesting period. The fair value of the market-conditioned performance stock units ($14.10 per unit) was determined at the grant date using a Monte Carlo simulation model and will be recognized as stock-based compensation expense on a straight-line basis net of actual forfeitures over the vesting period. Dividend equivalents are not paid on the stock awards described above. The expense associated with these awards were $6 million and $9 million for the three and nine months ended December 31, 2023, respectively.
32
Management Discussion (continued)
Transaction-Related Costs (Benefits)
The Company classifies certain expenses and benefits related to the Separation, acquisitions and divestitures (if any) as “transaction-related costs (benefits)” in the Consolidated Income Statement. Transaction-related costs include expenditures incurred to prepare for and execute the Separation and establish Kyndryl as a standalone business. These include employee retention expenses, information technology costs, marketing expenses to establish the Kyndryl brand, legal, accounting, consulting and other professional service costs required to prepare for and execute the Separation, costs and benefits resulting from settlements with our former Parent associated with pre-Separation and Separation-related matters, and other costs related to contract and supplier novation and integration.
Workforce Rebalancing and Site-Rationalization Charges
During the fiscal year ending March 31, 2023, management initiated certain actions to reduce our overall cost structure and increase our operating efficiency. These actions include workforce rebalancing charges, charges related to ceasing to use leased and owned fixed assets, and charges related to lease terminations. Workforce rebalancing charges arise from cost-reduction actions to enhance productivity and cost-competitiveness and to rebalance skills that result in payments to the terminated employees. In addition, we identified certain leased and owned assets that were inherited from IBM as a result of the Separation that we determined will no longer provide any economic benefit to Kyndryl. As a result, we disposed of these assets through abandonment or early termination. During the three months ended December 31, 2023, the Company recognized $19 million in workforce rebalancing charges and $14 million in charges related to ceasing to use leased and owned fixed assets and lease termination charges. During the nine months ended December 31, 2023, the Company recognized $115 million in workforce rebalancing charges and $24 million in charges related to ceasing to use leased and owned fixed assets and lease termination charges.
Management expects total future charges for this program to be approximately $25 million, primarily relating to workforce rebalancing. The Company estimates that the program in aggregate will require a cash outlay of approximately $300 million, of which approximately $170 million has been paid through December 31, 2023 (including $30 million of contractual payments toward leased assets we have ceased to use) and approximately $60 million is expected to be paid through the end of fiscal year 2024, and the remainder thereafter. Management expects that these workforce rebalancing and site-rationalization activities will reduce payroll costs, rent expenses and depreciation of property and equipment by approximately $300 million in fiscal year 2024. There can be no guarantee that we will achieve our expected cost savings. The Company will continue to seek opportunities to improve operational efficiency and reduce costs, which may result in additional charges in future periods. For additional information, see Note 14 – Workforce Rebalancing and Site-Rationalization Charges in the accompanying Consolidated Financial Statements.
Income Taxes
The provision for income taxes for the three months ended December 31, 2023 was $65 million of expense, compared to a $32 million benefit for the three months ended December 31, 2022. Our income tax expense for the three months ended December 31, 2023 was primarily related to taxes on foreign operations, uncertain tax positions and valuation allowances recorded in certain jurisdictions against deferred tax assets that are not more likely than not to be realized. Our income tax benefits for the three months ended December 31, 2022 were primarily due to return-to-provision adjustments related to the filing of income tax returns.
The provision for income taxes for the nine months ended December 31, 2023 was $131 million of expense, compared to $74 million of expense for the nine months ended December 31, 2022. Our income tax expense for the nine months ended December 31, 2023 was primarily related to taxes on foreign operations and valuation allowances recorded in certain jurisdictions against deferred tax assets that are not more likely than not to be realized. Our income tax expense for the nine months ended December 31, 2022 was primarily related to taxes on foreign operations and an increase in valuation allowances against deferred tax assets that are not more likely than not to be realized, partially offset by the benefit resulting from return-to-provision adjustments related to the filing of income tax returns.
33
Management Discussion (continued)
In assessing the need for a valuation allowance, management considers all available evidence for each jurisdiction, including past operating results, estimates of future taxable income, the reversal of existing temporary differences, and the feasibility of ongoing tax planning strategies and actions. Estimates of future taxable income and loss could change, perhaps materially, which may require us to revise our assessment of the recoverability of the deferred tax asset at that time.
Financial Position
Dynamics
Total assets of $11.0 billion decreased by $495 million (and decreased by $572 million adjusted for currency) from March 31, 2023, primarily driven by: a decrease in deferred costs of $326 million due to amortization outpacing additions; and a decrease in cash and cash equivalents of $159 million mainly due to our net loss in the period; partially offset by an increase of $135 million in accounts receivable due to the timing of billing and collection and the release of reserves for certain receivables from our former Parent.
Total liabilities of $9.7 billion decreased by $326 million (and decreased by $352 million adjusted for currency) from March 31, 2023, primarily as a result of: a decrease in accounts payable of $297 million due to lower costs and the timing of payments; and a decrease in deferred income of $63 million; partially offset by an increase in accrued contract costs of $169 million due to the timing of vendors’ billings.
Total equity of $1.3 billion decreased $169 million from March 31, 2023, principally due to our comprehensive loss in the period.
Working Capital
December 31, | March 31, | |||||
(Dollars in millions) |
| 2023 |
| 2023 | ||
Current assets |
| $ | 4,851 |
| $ | 4,963 |
Current liabilities |
| 5,152 |
| 4,868 | ||
Working capital | $ | (301) | $ | 95 |
Working capital decreased $396 million from March 31, 2023. Current assets decreased $112 million (and decreased $128 million adjusted for currency) primarily driven by: a decrease of $159 million in cash and cash equivalents and a decrease of $147 million in deferred costs (current); partially offset by an increase of $135 million in accounts receivable. Current liabilities increased $285 million (and increased $269 million adjusted for currency) driven by the $500 million floating-rate term loan due in November 2024 being classified as a current liability and an increase in accrued contract costs of $169 million; partially offset by a decrease in accounts payable of $297 million.
Noncurrent Assets and Liabilities
Noncurrent assets of $6.1 billion at December 31, 2023 decreased by $383 million (and decreased by $444 million adjusted for currency) compared to March 31, 2023, driven by a decrease in deferred costs (noncurrent) of $179 million; a decrease in operating right-of-use assets of $49 million; and a decrease in deferred tax assets of $41 million.
Noncurrent liabilities of $4.5 billion at December 31, 2023 decreased by $610 million (and decreased by $620 million adjusted for currency) compared to March 31, 2023, mainly driven by the $500 million floating-rate term loan due in November 2024 being classified as a current liability and a decrease in deferred income (noncurrent) of $36 million.
34
Management Discussion (continued)
Cash Flow
Our cash flows from operating, investing and financing activities are summarized in the table below.
Nine Months Ended December 31, | ||||||
(Dollars in millions) |
| 2023 |
| 2022 | ||
Net cash provided by (used in): |
|
|
| |||
Operating activities | $ | 309 | $ | 769 | ||
Investing activities |
| (350) |
| (699) | ||
Financing activities |
| (123) |
| (100) | ||
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
| (5) |
| (109) | ||
Net change in cash, cash equivalents and restricted cash | $ | (169) | $ | (138) |
Net cash provided by operating activities was $309 million in the nine months ended December 31, 2023, compared to net cash provided of $769 million in the prior-year period mainly due to the timing of receivable collections and vendor payments.
Net cash used in investing activities was $350 million in the nine months ended December 31, 2023, compared to a net cash use of $699 million in the prior-year period due to lower capital expenditures.
Net cash used in financing activities totaled $123 million in the nine months ended December 31, 2023, compared to net cash used in financing activities of $100 million in the prior-year period.
Other Information
Signings
The following table presents the Company’s signings for the three and nine months ended December 31, 2023 and 2022.
| Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||
(Dollars in billions) |
| 2023 |
| 2022 | 2023 |
| 2022 | |||||
Total signings | $ | 3.7 | $ | 3.2 | $ | 8.9 | $ | 8.6 |
Signings increased by $492 million in the three months ended December 31, 2023, or 15%, compared to the prior-year quarter. Signings increased by $289 million in the nine months ended December 31, 2023, or 3%, compared to the nine months ended December 31, 2022. We believe that the estimated values of signings provide insight into the Company’s potential future revenue and are a tool to monitor trends in the business, including the business’ ability to attract new customers and sell additional scope into our existing customer base, and we believe signings are helpful information for investors. There are no third-party standards or requirements governing the calculation of signings. We define signings as an initial estimate of the value of a customer’s commitment under a contract. The calculation involves estimates and judgments to gauge the extent of a customer’s commitment, including the type and duration of the agreement and the presence of termination charges or wind-down costs. Contract extensions and increases in scope are treated as signings only to the extent of the incremental new value. Signings can vary over time due to a variety of factors including, but not limited to, the timing of signing a small number of larger outsourcing contracts as well as the length of those contracts. The conversion of signings into revenue may vary based on the types of services and solutions, customer decisions and other factors, which may include, but are not limited to, the macroeconomic environment or external events.
35
Management Discussion (continued)
Liquidity and Capital Resources
We believe that our existing cash and cash equivalents and the Revolving Credit Agreement entered into in October 2021, will be sufficient to meet our anticipated cash needs for at least the next twelve months.
Senior Unsecured Notes
In October 2021, in preparation for our Spin-off, we completed the offering of $2.4 billion in aggregate principal amount of senior unsecured fixed-rate notes as follows: $700 million aggregate principal amount of 2.05% Senior Notes due 2026, $500 million aggregate principal amount of 2.70% Senior Notes due 2028, $650 million aggregate principal amount of 3.15% Senior Notes due 2031 and $550 million aggregate principal amount of 4.10% Senior Notes due 2041 (the “Notes”). The Notes were offered and sold to qualified institutional buyers in reliance on Rule 144A under the Securities Act and to non-U.S. persons in reliance on Regulation S of the Securities Act. The Notes are subject to customary affirmative covenants, negative covenants and events of default for financings of this type and are redeemable at our option in a customary manner.
In connection with the issuance of the Notes, we entered into a registration rights agreement with the initial purchasers of the Notes, pursuant to which we completed a registered offering to exchange each series of Notes for new notes with substantially identical terms during the quarter ended September 30, 2022.
Term Loan and Revolving Credit Facility
In October 2021, we entered into a $500 million three-year variable rate term loan credit agreement (the “Term Loan Credit Agreement”). In November 2021, we drew down the full $500 million available under the Term Loan Credit Agreement. The term loan due in November 2024 became classified as a current liability in November 2023. We intend to refinance this term loan in the first half of calendar year 2024, prior to its maturity, subject to market conditions.
In October 2021, we entered into a $3.15 billion multi-currency revolving credit agreement (the “Revolving Credit Agreement” and, together with the Term Loan Credit Agreement, the “Credit Agreements”) for our future liquidity needs.
In June 2023, we amended the Credit Agreements by replacing the London Interbank Offered Rate (“LIBOR”) as the interest rate benchmark for U.S. Dollar borrowings with the Secured Overnight Financing Rate (“SOFR”). The first repricing date using SOFR was in July 2023.
The Revolving Credit Agreement expires, unless extended, in October 2026, and the Term Loan Credit Agreement matures, unless extended, in November 2024. Interest rates on borrowings under the Credit Agreements are based on prevailing market interest rates, plus a margin, as further described in the Credit Agreements. As of December 31, 2023, there were no borrowings under the Revolving Credit Agreement.
We may voluntarily prepay our debt without premium or penalty, subject to customary “breakage” costs. The Company is in compliance with all of its debt covenants for all periods presented.
Transfers of Financial Assets
The Company has entered into agreements with third-party financial institutions to sell certain financial assets (primarily trade receivables) without recourse. The Company has determined these are true sales. The carrying value of the financial asset sold is derecognized, and a net gain or loss on the sale is recognized, at the time of the transfer. The first agreement, which was executed in November 2021 and subsequently amended, enabled us to sell certain of our trade receivables to the counterparty. The initial term of this agreement was 18 months, and the agreement automatically
36
Management Discussion (continued)
resets to a term of 18 months after every six months, unless either party elects not to extend. The second agreement was executed in June 2022 with a separate third-party financial institution and renews automatically on its anniversary date.
The net proceeds from these agreements are reflected as cash provided by operating activities in the Consolidated Statement of Cash Flows. Gross proceeds from receivables sold to third parties under such programs were $846 million and $2.9 billion for the three and nine months ended December 31, 2023, respectively, and $930 million and $2.3 billion for the three and nine months ended December 31, 2022, respectively. The fees associated with the transfers of receivables were $11 million and $39 million for the three and nine months ended December 31, 2023, respectively, and $14 million and $34 million for the three and nine months ended December 31, 2022, respectively.
Critical Accounting Estimates
The application of U.S. GAAP requires us to make estimates and assumptions about certain items and future events that directly affect our reported financial condition. There have been no changes to our critical accounting policies and estimates as described in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 for more information; we refer to the Annual Report on Form 10-K for the fiscal year ended March 31, 2023 as the “Form 10-K”.
Cautionary Note Regarding Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this report, including, without limitation, statements concerning the Company’s plans, objectives, goals, beliefs, business strategies, future events, business condition, results of operations, financial position, business outlook and business trends and other non-historical statements in this report are forward-looking statements. Such forward-looking statements often contain words such as “will,” “anticipate,” “predict,” “project,” “contemplate,” “plan,” “forecast,” “future,” “estimate,” “expect,” “intend,” “target,” “may,” “should,” “would,” “could,” “outlook,” “goal,” “objective,” “seek,” “aim,” “believe” and other similar words or expressions or the negative thereof or other variations thereon. Forward-looking statements are based on the Company’s current assumptions and beliefs regarding future business and financial performance. The Company’s actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others:
● | risks related to the Company’s spin-off from IBM; |
● | failure to attract new customers, retain existing customers or sell additional services to customers; |
● | technological developments and the Company’s response to such developments; |
● | failure to meet growth and productivity objectives; |
● | competition; |
● | impacts of relationships with critical suppliers and partners; |
● | inability to attract, retain and/or manage key personnel and other skilled employees; |
● | impact of local legal, economic, political, health and other conditions; |
● | a downturn in economic environment and customer spending budgets; |
● | damage to the Company’s reputation; |
● | inability to accurately estimate the cost of services and the timeline for completion of contracts; |
● | its implementation of a new enterprise resource planning system and other systems and processes; |
● | service delivery issues; |
● | the Company’s ability to successfully manage acquisitions, alliances and dispositions, including integration challenges, failure to achieve objectives, the assumption of liabilities, and higher debt levels; |
● | the impact of our business with government customers; |
● | failure of the Company’s intellectual property rights to prevent competitive offerings and the failure of the Company to obtain necessary licenses; |
● | the impairment of our goodwill or long-lived assets; |
37
Management Discussion (continued)
● | risks relating to cybersecurity and data privacy; |
● | risks relating to non-compliance with legal and regulatory requirements; |
● | adverse effects from tax matters and environmental matters; |
● | legal proceedings and investigatory risks and potential indemnification obligations; |
● | impact of changes in market liquidity conditions and customer credit risk on receivables; |
● | the Company’s pension plans; |
● | the impact of currency fluctuations; and |
● | risks related to the Company’s common stock and the securities market. |
Additional risks and uncertainties include, among others, those risks and uncertainties described in the “Risk Factors” section of our Form 10-K for the fiscal year ended March 31, 2023, as such factors may be updated from time to time in the Company’s subsequent filings with the SEC. Any forward-looking statement in this report speaks only as of the date on which it is made. Except as required by law, the Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Website and Social Media Disclosure
The Company may use its website and/or social media outlets, such as Facebook, LinkedIn and X (formerly Twitter), as distribution channels of material company information. Financial and other important information regarding the Company is routinely posted on and accessible through the Company’s website at https://investors.kyndryl.com, its Facebook page at https://www.facebook.com/kyndryl, its LinkedIn page at https://linkedin.com/company/kyndryl and its X (formerly Twitter) account (@Kyndryl) at https://X.com/Kyndryl. We may also use our Investors Relations website, https://investors.kyndryl.com, as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the “Investor Email Alerts” section under the “Resources” section at https://investors.kyndryl.com.
38
Item 3. Quantitative and Qualitative Disclosures About Market Risk
For our disclosures about market risk, see the information under the heading “Quantitative and Qualitative Disclosures About Market Risk” in the Form 10-K. There have been no material changes to the Company’s disclosure about market risk in the Form 10-K.
Item 4. Controls and Procedures
The Company’s management evaluated, with the participation of the Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
During the nine months ended December 31, 2023, we completed the implementation of a new enterprise resource planning system. The implementation included changes to certain financial processes impacting key controls related to our internal controls over financial reporting. We have updated our internal controls as appropriate in light of the system implementation and will continue to monitor the impact of the implementation on our processes, procedures and internal control over financial reporting. There have been no other changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
39
Part II — Other Information
Item 1. Legal Proceedings
Refer to Note 10 – Commitments and Contingencies, in the notes to consolidated financial statements in this report.
Item 1A. Risk Factors
For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Form 10-K for the year ended March 31, 2023. There have been no material changes with respect to the risk factors disclosed in the Form 10-K.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
None.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended December 31, 2023,
40
Item 6. Exhibits
Exhibit Number | Description of Exhibit |
2.1 | |
3.1 | |
3.2 | |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
101.INS | XBRL Instance Document – the instance document does not appear on the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
101.SCH | XBRL Taxonomy Extension Schema Document |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
104 | Cover Page Interactive Data File – the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
The agreements and other documents filed as exhibits to this report are not intended to provide factual information or other disclosure other than with respect to the terms of the agreements or other documents themselves, and you should not rely on them for that purpose. In particular, any representations and warranties made by the Company in these agreements or other documents were made solely within the specific context of the relevant agreement or document and do not apply in any other context or at any time other than the date they were made.
41
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Kyndryl Holdings, Inc. | ||||
(Registrant) | ||||
Date: | February 7, 2024 | |||
By: | /s/ Vineet Khurana | |||
Vineet Khurana | ||||
Senior Vice President and Global Controller (Principal Accounting Officer and Authorized Signatory) |
42
Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
I, Martin J. Schroeter, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Kyndryl Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 7, 2024
| /s/ Martin J. Schroeter |
| Martin J. Schroeter |
| Chairman and Chief Executive Officer |
| (Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
I, David B. Wyshner, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Kyndryl Holdings, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: February 7, 2024
| /s/ David B. Wyshner |
| David B. Wyshner |
| Chief Financial Officer |
| (Principal Financial Officer) |
Exhibit 32.1
KYNDRYL HOLDINGS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kyndryl Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Martin J. Schroeter, Chairman and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 7, 2024
| /s/ Martin J. Schroeter |
| Martin J. Schroeter |
| Chairman and Chief Executive Officer |
| (Principal Executive Officer) |
Exhibit 32.2
KYNDRYL HOLDINGS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Kyndryl Holdings, Inc. (the “Company”) on Form 10-Q for the quarterly period ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David B. Wyshner, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 7, 2024
| /s/ David B. Wyshner |
| David B. Wyshner |
| Chief Financial Officer |
| (Principal Financial Officer) |